Sign in
Taking peopleNo phase

Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression

Key facts

Who runs it
Beijing Tongren Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
120 people, planned
Started
2 Aug 2024
Planned end
30 Sept 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses
Record updated
7 January 2026

Who can take part

Age
6 years to 14 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 6-14 years
  • Myopic spherical equivalent refraction between -0.75D and -4.00D (inclusive of -0.75D and -4.00D, based on cycloplegic refraction)
  • Astigmatism ≤1.50D
  • Anisometropia ≤1.50D
  • Best-corrected visual acuity (BCVA) reaching 5.0 (0.00 LogMAR) or better in both eyes; monocular BCVA reaching 5.0 (0.00 LogMAR) or better after wearing myopic defocus spectacles
  • Absence of organic ocular diseases
  • No history of myopia control treatment within the past three months, including orthokeratology, progressive multifocal lenses, peripheral defocus spectacle lenses, bifocal spectacle lenses, defocus-designed soft hydrophilic contact lenses, other myopia control medications, or light-therapy devices
  • Voluntary participation in this clinical study and provision of signed informed consent

Who cannot take part

  • History of ocular trauma or surgery
  • Systemic diseases affecting visual function
  • Inability to cooperate with examinations
  • Poor compliance
  • Inability to adhere to wearing requirements and follow-up visits during the trial period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 14 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Clinical Trial

Read full original descriptionShow less

The goal of this clinical trial is to evaluate the effectiveness of two types of Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses in slowing myopia progression in children. It will also assess the safety of these lenses. The main questions it aims to answer are:

Do D.S.D.O. lenses reduce the progression of myopia as measured by changes in cycloplegic refraction and axial length? What adverse events do participants experience when wearing D.S.D.O. lenses? Researchers will compare two optical designs of D.S.D.O. lenses (Intervention Group1: Design 1; Intervention Group2: Design 2) to determine their relative efficacy in controlling myopia progression.

Participants will:

Wear assigned D.S.D.O. lenses daily for 12 months (except during sleep or unavoidable situations).

Attend clinic visits at baseline, 3, 6, 9, and 12 months for comprehensive eye examinations.

Maintain a diary recording daily wear time, visual symptoms, and any adverse events.

The 2 groups in the trial

  • Multi-lens zoning myopia defocus Lens 1 (D.S.D.O)Treatment being tested

    Treatment: Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses

  • Multi-lens zoning myopia defocus Lens 2(D.S.D.O)Treatment being tested

    Treatment: Diverse Segments Defocus Optimization (D.S.D.O.) spectacle lenses

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07323251, who can take part
Record updated
7 January 2026